Health product recall

CellChem Pharmaceuticals Ondansetron Product Recall (2019-10-16)

Starting date:
October 16, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-71337

Last updated: 2019-10-18

Summary

  • Product:
    A.  CCP-Ondansetron 8 mg Tablet;    

    B.  CCP-Ondansetron 4 mg Tablet

A.  CCP-Ondansetron 8 mg Tablet;   

B.  CCP-Ondansetron 4 mg Tablet

Reason

Affected lot is labelled with the incorrect indication found on the inner label.

Depth of distribution

Retailers

Affected products

A.  CCP-Ondansetron 8 mg Tablet

DIN, NPN, DIN-HIM

DIN 02458802

Dosage form

Tablet

Strength

Ondansetron 8 mg

Lot or serial number

409424

Companies

Recalling Firm

Cellchem Pharmaceuticals Inc

Unit 1, 30 Concourse Gate,

Ottawa

K2E 7V7

Ontario

CANADA

Marketing Authorization Holder

Cellchem Pharmaceuticals Inc

Unit 1, 30 Concourse Gate,

Ottawa

K2E 7V7

Ontario

CANADA

B.  CCP-Ondansetron 4 mg Tablet

DIN, NPN, DIN-HIM

DIN 0245880

Dosage form

Tablet

Strength

Ondansetron 4 mg

Lot or serial number

409423

Companies

Recalling Firm

Cellchem Pharmaceuticals Inc

Unit 1, 30 Concourse Gate,

Ottawa

K2E 7V7

Ontario

CANADA

Marketing Authorization Holder

Cellchem Pharmaceuticals Inc

Unit 1, 30 Concourse Gate,

Ottawa

K2E 7V7

Ontario

CANADA